These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 570740)

  • 1. Correlation of sulfate content and degree of carboxylation of heparin and related glycosaminoglycans with anticomplement activity. Relationships to the anticoagulant and platelet-aggregating activities.
    Cofrancesco E; Radaelli F; Pogliani E; Amici N; Torri GG; Casu B
    Thromb Res; 1979 Jan; 14(1):179-87. PubMed ID: 570740
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physico-chemical characteristics of heparin in relation to its anticoagulant and anti-hemostatic action].
    Nader HB; Dietrich CP; Straus AH; Takahashi HK
    Rev Bras Biol; 1979 Nov; 39(4):793-816. PubMed ID: 162073
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heparin-like anticoagulant as part of global abnormalities of plasma glycosaminoglycans in a patient with transitional cell carcinoma.
    Horne MK; Chao ES; Wilson OJ; Scialla SJ; Lynch MA; Kragel PJ
    J Lab Clin Med; 1991 Sep; 118(3):250-60. PubMed ID: 1919298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA; Petäjä J; Griffin JH
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between glycosaminoglycans, platelets, and leukocytes.
    Cerletti C; Rajtar G; Marchi E; de Gaetano G
    Semin Thromb Hemost; 1994; 20(3):245-53. PubMed ID: 7824958
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure and biological activity of heparin and other glycosaminoglycans.
    Casu B
    Pharmacol Res Commun; 1979 Jan; 11(1):1-18. PubMed ID: 370843
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glycosaminoglycans and erythrocyte and platelet aggregation in joint diseases].
    Puchin'ian DM; Kosiagin DV; Mitrofanov VA
    Sov Med; 1990; (1):54-7. PubMed ID: 2349517
    [No Abstract]   [Full Text] [Related]  

  • 11. Coagulation protein function: enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans.
    Brecher AS; Adamu MT
    Dig Dis Sci; 2001 Sep; 46(9):2033-42. PubMed ID: 11575460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of acidic glycosaminoglycans in the intima, media and adventitia of bovine aorta and their anticoagulant properties.
    Murata K; Nakazawa K; Hamai A
    Atherosclerosis; 1975; 21(1):93-103. PubMed ID: 124175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemical and anticoagulant nature of heparin.
    Jaques LB; McDuffie NM
    Semin Thromb Hemost; 1978; 4(4):277-97. PubMed ID: 150031
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin: do we understand its antithrombotic actions?
    Cines DB
    Chest; 1986 Mar; 89(3):420-6. PubMed ID: 3512191
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro blood compatibility of glycosaminoglycan-precipitated collagens.
    Silver FH; Yannas IV; Salzman EW
    J Biomed Mater Res; 1979 Sep; 13(5):701-16. PubMed ID: 479217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrodynamic properties of connective-tissue polysaccharides.
    Comper WD; Zamparo O
    Biochem J; 1990 Aug; 269(3):561-4. PubMed ID: 2117916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionation of heparin, dermatan sulfate, and chondroitin sulfate by sequential precipitation: a method to purify a single glycosaminoglycan species from a mixture.
    Volpi N
    Anal Biochem; 1994 May; 218(2):382-91. PubMed ID: 8074297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfated Alginates as Heparin Analogues: A Review of Chemical and Functional Properties.
    Arlov Ø; Skjåk-Bræk G
    Molecules; 2017 May; 22(5):. PubMed ID: 28492485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.
    Hoppensteadt DA; Walenga JM; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 1():60-4. PubMed ID: 2068572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of platelet factor four and glycosaminoglycans.
    Loscalzo J; Melnick B; Handin RI
    Arch Biochem Biophys; 1985 Jul; 240(1):446-55. PubMed ID: 2409923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.